Literature DB >> 33060410

Mobile Extracorporeal Membrane Oxygenation.

Antonio F Corno1,2, Gail M Faulkner1, Chris Harvey1.   

Abstract

To review our experience with mobile extracorporeal membrane oxygenation (ECMO). Mobile ECMO team included: ECMO-trained surgeon and intensivist, specialist nurse, and perfusionist. Patients were cannulated for venous-arterial (V-A) or venous-venous (V-V) ECMO, depending on clinical indication. Mobile transfers were carried out utilizing a Levitronics Centrimag centrifugal pump and Hico Variotherm 555 heater cooler. From October 2009 to May 2019, 571 patients, 185 (32%) neonates, 95 (17%) pediatric, and 291 (51%) adults, underwent mobile ECMO transfer. Four hundred fifty-three (79%) transfers were completed by road, 76 (13%) by air, and 42 (8%) by road/air combination. Road was the travel mode of choice for journeys with expected duration up to 3 hours one way. Nevertheless, road transfers up to 6 hours duration were performed safely. Average duration of mobile ECMO transfer was 5.5 hours (2-18 hours). Two patients died before arrival of mobile ECMO team, four patients were cannulated during cardio-pulmonary resuscitation, and one of them died of uncontrollable hemorrhage in the right hemithorax. One patient had cardiac arrest after V-V cannulation and required conversion to V-A. Mobile ECMO is safe and reliable to transfer the sickest of patients. Fully trained team with all equipment and disposables is indispensable for reliable mobile ECMO service.
Copyright © ASAIO 2020.

Entities:  

Year:  2021        PMID: 33060410     DOI: 10.1097/MAT.0000000000001286

Source DB:  PubMed          Journal:  ASAIO J        ISSN: 1058-2916            Impact factor:   2.872


  2 in total

Review 1.  A narrative review of modern approach and outcomes evaluation in congenital heart defects.

Authors:  Antonio F Corno; Damien J LaPar; Wen Li; Jorge D Salazar
Journal:  Transl Pediatr       Date:  2021-08

Review 2.  Pediatric and neonatal extracorporeal life support: current state and continuing evolution.

Authors:  Brian P Fallon; Samir K Gadepalli; Ronald B Hirschl
Journal:  Pediatr Surg Int       Date:  2021-01-01       Impact factor: 1.827

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.